SNDX
Syndax Pharmaceuticals Inc
NASDAQ · Healthcare · Biotechnology · US
$14.15
−1.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 40.51x
- P/S forward
- 4.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 83.68x
- Price / sales
- 5.01x
- Price / cash flow
- -5.73x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 5.18x
- EV / EBITDA
- -9.65x
- EV / EBIT
- -6.72x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026